Published in Curr Neurol Neurosci Rep on December 01, 2013
Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive disorder. PLoS One (2014) 1.02
Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80
Effects of music and music therapy on mood in neurological patients. World J Psychiatry (2015) 0.80
Detecting depression in Parkinson disease: A systematic review and meta-analysis. Neurology (2016) 0.77
Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review. BMC Neurol (2016) 0.77
Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease. J Neurol (2016) 0.77
Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease. Mov Disord Clin Pract (2015) 0.77
The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease. Front Hum Neurosci (2016) 0.75
Long-term effect of sub-anesthetic ketamine in reducing l-DOPA-induced dyskinesias in a preclinical model. Neurosci Lett (2015) 0.75
Speech-related fatigue and fatigability in Parkinson's disease. Clin Linguist Phon (2014) 0.75
Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias. Case Rep Neurol (2016) 0.75
Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study. PLoS One (2016) 0.75
Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease. J Neurol (2015) 0.75
Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders. Mov Disord Clin Pract (2016) 0.75
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol (2006) 5.40
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord (2002) 3.00
A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology (2008) 2.97
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord (2005) 2.68
Executive dysfunction and the course of geriatric depression. Biol Psychiatry (2005) 2.56
Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand (2004) 2.47
The impact of depressive symptoms in early Parkinson disease. Neurology (2007) 2.37
Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol (2010) 2.33
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.26
Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord (2002) 2.21
Neuropsychiatric symptoms in Parkinson's disease. Mov Disord (2009) 2.20
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord (2011) 2.05
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry (2011) 1.95
A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 1.93
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology (2012) 1.77
Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord (2006) 1.76
Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord (2013) 1.74
Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med (1988) 1.72
Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol (2003) 1.71
Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol (2000) 1.71
Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2001) 1.70
Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol (2011) 1.69
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study. Mov Disord (2010) 1.64
Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62
Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology (2010) 1.58
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. Mov Disord (2012) 1.54
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry (2013) 1.52
Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry (1993) 1.51
A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand (2006) 1.49
Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci (2011) 1.47
Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial. Arch Gen Psychiatry (2009) 1.43
Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease. Parkinsonism Relat Disord (2006) 1.43
Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry (2011) 1.43
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol (1990) 1.41
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology (2007) 1.38
Depression in Parkinson's disease. J Nerv Ment Dis (1990) 1.29
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol (2003) 1.28
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord (2008) 1.27
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry (2013) 1.20
The STAR*D study: treating depression in the real world. Cleve Clin J Med (2008) 1.20
Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry (1990) 1.19
Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord (2003) 1.19
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA. Acta Neurol Scand (1980) 1.19
Suicidal and death ideation in Parkinson's disease. Mov Disord (2008) 1.17
Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord (1998) 1.15
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med (2005) 1.15
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology (2010) 1.15
Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.10
Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology (2004) 1.10
A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology (2012) 1.09
Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord (2008) 1.07
Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry (2001) 1.05
Nonmotor symptoms in genetic Parkinson disease. Arch Neurol (2010) 1.03
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group. Neurology (1997) 1.03
Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry (2007) 1.02
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. J Neurol (2006) 1.01
Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat (2008) 1.01
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol (2010) 1.00
The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review. Drugs (2011) 0.99
Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol (1990) 0.99
Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study. Parkinsonism Relat Disord (2012) 0.99
Markers for depression in Parkinson's disease. Acta Psychiatr Scand (2002) 0.97
Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol (2011) 0.96
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord (2005) 0.95
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94
Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol (1995) 0.93
Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter. J Geriatr Psychiatry Neurol (1999) 0.92
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci (2010) 0.91
Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord (2011) 0.91
Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings (2009) 0.91
LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort. Parkinsonism Relat Disord (2010) 0.89
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Mov Disord (2009) 0.89
Prevalence of depression in Parkinson's disease: effects of disease stage, motor subtype and gender. J Neurol Sci (2011) 0.89
A validation study of depressive syndromes in Parkinson's disease. Mov Disord (2008) 0.88
The course of depressive symptoms in early Parkinson's disease. Mov Disord (2009) 0.87
Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus? Neuropharmacology (2011) 0.86
The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Exp Brain Res (2013) 0.86
Depression in Parkinson's disease. Diffusion tensor imaging study. J Neurol (2006) 0.86
Barriers to mental health care utilization in Parkinson's disease. J Geriatr Psychiatry Neurol (2013) 0.85
Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report. Parkinsonism Relat Disord (2007) 0.85
Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor. Mov Disord (2003) 0.84
Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Mov Disord (2012) 0.83
Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2002) 0.83
Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. J Neurol Neurosurg Psychiatry (2007) 0.83
Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov Disord (1991) 0.83
Minor depression and brain perfusion images in Parkinson's disease. Mov Disord (2006) 0.81
Major life events and development of major depression in Parkinson's disease patients. Eur J Neurol (2012) 0.81
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry (2011) 0.81
The effect of psychotherapy in patients with PD: a controlled study. Parkinsonism Relat Disord (2009) 0.80
The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat Disord (2011) 0.80
Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis (2012) 0.79
The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment. Acta Neurol Scand (2010) 0.78
Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships? J Neurol Neurosurg Psychiatry (2013) 0.78
No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese. Neurosci Lett (2009) 0.77